CardiotoxinsAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinAntibiotics, AntineoplasticRazoxaneAnthracyclinesChemotherapy, AdjuvantHeart DiseasesHydroxyethylrutosideAntineoplastic AgentsHeartCyclophosphamideCardiomyopathiesCombined Modality TherapyCisplatinTreatment OutcomeBreast NeoplasmsDaunorubicinMyocardiumDrug Administration ScheduleDisease-Free SurvivalNeoadjuvant TherapyMyocytes, CardiacSurvival AnalysisNeoplasmsNeoplasm StagingCardiotonic AgentsSurvival RateEtoposidePaclitaxelDexrazoxaneEpirubicinPrognosisDose-Response Relationship, DrugTaxoidsMitoxantroneAntibodies, Monoclonal, HumanizedAntimetabolites, AntineoplasticLung NeoplasmsMethotrexateTime FactorsCarboplatinDeoxycytidineInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalDrug-Related Side Effects and Adverse ReactionsFollow-Up StudiesEthyl EthersIfosfamideDrug Resistance, NeoplasmNeoplasm MetastasisNeutropeniaButylaminesBleomycinClinical Trials as TopicOrganoplatinum CompoundsAntineoplastic Agents, PhytogenicLymphoma, Non-HodgkinApoptosisVentricular Function, LeftIdarubicinElectrocardiographyProspective StudiesAntibodies, MonoclonalDrug Evaluation, PreclinicalAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungVentricular Dysfunction, LeftInfusions, IntravenousOvarian NeoplasmsMitochondria, HeartReceptor, erbB-2Precursor Cell Lymphoblastic Leukemia-LymphomaTesticular NeoplasmsHeart FailureVomitingTransplantation, AutologousAdenocarcinomaNauseaCyclooctanesCreatine KinaseEchocardiographyTroponin IRadiotherapy, AdjuvantHodgkin DiseaseSarcomaColorectal NeoplasmsRadiotherapyFluoroacetatesCell Line, TumorDacarbazineChemical EngineeringProtective AgentsNeoplasms, Germ Cell and EmbryonalCarmustineOxidative Stress